Marshall Wace’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Marshall Wace’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,501,283	Closed	-$32M	–	3102
2024 Q1	$32M	Buy	1,501,283 +1,182,843	+371%	+$14.1M	0.05%	357
2023 Q4	$3.06M	Buy	+318,440	New	+$1.55M	0.01%	1070

Marshall Wace's FUSN Position: Q2 2024 in Review

Marshall Wace sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 1,501,283 shares — an estimated $32M sold.

Marshall Wace first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $32M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Marshall Wace reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Marshall Wace sold 1,501,283 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $32M.
Marshall Wace first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Marshall Wace's Fusion Pharmaceuticals Inc. Common Shares position peaked at $32M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.